Fortrea Holdings

FTRE

Market cap $926M

Overview Fund Activity

10.20 USD

+0.10

0.99%

At close Updated Sep 15, 4:00 PM EDT

Pre-market

After hours

10.20

0.00

0%

1 day

0.99%

5 days

-0.2%

1 month

26.87%

3 months

76.17%

6 months

2.2%

Year to date

-45.31%

1 year

-52.97%

5 years

-66.11%

10 years

-66.11%

About: Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Employees: 14,500

Healthcare Biotechnology

0

Funds holding %

of 7,463 funds

0

Analysts bullish %

of 5 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

166% more call options, than puts

Call options by funds: $7.02M | Put options by funds: $2.64M

16% more repeat investments, than reductions

Existing positions increased: 108 | Existing positions reduced: 93

6.05% more ownership

Funds ownership: 104.42% [Q1] → 110.47% (+6.05%) [Q2]

6% less funds holding

Funds holding: 357 [Q1] → 334 (-23) [Q2]

25% less first-time investments, than exits

New positions opened: 61 | Existing positions closed: 81

31% less capital invested

Capital invested by funds: $711M [Q1] → $494M (-$218M) [Q2]

See Fund Rankings

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$6

41% downside

Avg. target

$8.7

15% downside

High target

$14

37% upside

5 analyst ratings

1 positive

20%

3 neutral

60%

1 negative

20%

Jefferies David Windley	$9.5	Hold Maintained	9 Sep 2025
Baird Eric Coldwell	$14	Outperform Maintained	3 Sep 2025
Evercore ISI Group Elizabeth Anderson	$7	In-Line Maintained	8 Aug 2025
Barclays Luke Sergott	$6	Underweight Maintained	7 Aug 2025
Mizuho Ann Hynes	$7	Neutral Maintained	11 Jul 2025

See Analyst Rankings

Financial journalist opinion

Based on 3 articles about FTRE published over the past 30 days

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

DURHAM, N.C., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization, today announced the granting of an inducement award of restricted stock units (“RSUs”) on September 12, 2025, to one newly hired employee. The award consisted of 75,000 RSUs that vest in three equal annual installments starting September 12, 2026, subject to the employee's continuous employment through the applicable vesting date. The RSUs are subject to the terms and conditions of the Company's Amended and Restated 2025 Inducement Award Plan and the award agreements covering the grants. These awards follow Nasdaq Listing Rule 5635(c)(4) and are intended as an inducement material to the individual becoming a new employee of the Company.

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Kuehn Law Encourages Investors of Fortrea Holdings, Inc. to Contact Law Firm

NEW YORK , Sept. 9, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Fortrea Holdings, Inc. (NASDAQ: FTRE) breached their fiduciary duties to shareholders.

Kuehn Law Encourages Investors of Fortrea Holdings, Inc. to Contact Law Firm

Investors who lost money with Fortrea Holdings Inc. (NASDAQ: FTRE) should contact the Shareholders Foundation in connection with Lawsuit

SAN DIEGO , Aug. 25, 2025 /PRNewswire/ -- Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in NASDAQ: FTRE shares over alleged securities laws violations by Fortrea Holdings Inc. Investors who purchased shares of Fortrea Holdings Inc. prior to July 2023 and continue to hold any of those NASDAQ: FTRE shares also have certain options and contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On May 23, 2025, a NASDAQ: FTRE investor filed a lawsuit against Fortrea Holdings Inc. The plaintiff alleged that the defendants made false and/or misleading statements and/or failed to disclose that Fortrea overestimated the amount of revenue the Pre-Spin Projects were likely to contribute to the Company's 2025 earnings, that Fortrea overstated the cost savings it would likely achieve by exiting the TSAs, that as a result, the Company's previously announced EBITDA targets for 2025 were inflated, that accordingly, the viability of the Company's post-Spin-Off business model, as well as its business and/or financial prospects, were overstated, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Investors who lost money with Fortrea Holdings Inc. (NASDAQ: FTRE) should contact the Shareholders Foundation in connection with Lawsuit

Fortrea Holdings Inc. (FTRE) Q2 2025 Earnings Call Transcript

Fortrea Holdings Inc. (NASDAQ:FTRE ) Q2 2025 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants Anshul Thakral - Corporate Participant Hima B. Inguva - Head of Investor Relations & Corporate Development Jill McConnell - Chief Financial Officer Peter M.

Fortrea Holdings Inc. (FTRE) Q2 2025 Earnings Call Transcript

The Motley Fool

Fortrea (FTRE) Q2 Revenue Jumps 7%

Fortrea (FTRE) Q2 Revenue Jumps 7%

Fortrea (FTRE) Q2 Revenue Jumps 7%

Zacks Investment Research

Fortrea Holdings Inc. (FTRE) Beats Q2 Earnings and Revenue Estimates

Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to a loss of $0.03 per share a year ago.

Fortrea Holdings Inc. (FTRE) Beats Q2 Earnings and Revenue Estimates

Fortrea Reports Second Quarter 2025 Results

For the three months ended June 30, 2025, from continuing operations: Revenues of $710.3 million GAAP net loss of $(374.9) million, inclusive of a non-cash goodwill impairment charge Adjusted EBITDA of $54.9 million GAAP and adjusted net (loss) income per diluted share of $(4.14) and $0.19, respectively Book-to-bill ratio of 0.79x, resulting in 1.10x book-to-bill for the trailing 12 months Cost saving initiatives remain on track Raising 2025 revenue guidance to a range of $2,600 million to $2,700 million; affirming 2025 adjusted EBITDA guidance DURHAM, N.C., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today reported financial results for the second quarter ended June 30, 2025.

Fortrea Reports Second Quarter 2025 Results

Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations

DURHAM, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the appointment of Tracy Krumme as senior vice president, investor relations, succeeding Hima Inguva in this role, who has decided to pursue other career opportunities. Krumme will report to Chief Financial Officer, Jill McConnell, and lead Fortrea's global investor relations strategy, serving as a key liaison to the investment community.

Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

DURHAM, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it issued grants of employment inducement awards to Anshul Thakral, the Company's recently appointed President and Chief Executive Officer, as an inducement material to Mr. Thakral becoming a new employee of the Company. The grants were previously approved by the independent members of the Company's Board of Directors and were made in connection with Mr. Thakral's start date with the Company on August 4, 2025 (the “Effective Date”).

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE

NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fortrea Holdings, Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 25-cv-04630, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Fortrea securities between July 3, 2023 and February 28, 2025 both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE

See News Rankings

Charts implemented using Lightweight Charts™